.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Stakeholders

Academia
Employers
Health System
Payers
Providers

Topics

Clinical
Health Care Cost
Health Care Delivery
Insurance
Policy
Technology
Value-Based Care

Institute for Value-Based Medicine

All Coverage
Event Coverage
Interviews
News

About AJMC

AJMC Journals
Anniversary
Author Forms
Authors
Nominate a Rising Leader

About Us
Advertise
Contact
Do Not Sell My Information
Terms & Conditions
Privacy Policy

Effect of Off-Label Use of Oncology Drugs on Pharmaceutical Costs: The Rituximab Experience

May 1, 2003

Darren Kocs, MD, MHSA, A. Mark Fendrick, MDS

The American Journal of Managed Care, May 2003, Volume 9, Issue 5